US biotech Rezo Therapeutics today announced the appointment of Derek Hicks as its chief executive (CEO). With more than 25 ...

US pharma major Eli Lilly (NYSE: LLY) is partnering with the UK’s Department for Science, Innovation and Technology to fund ...

UK and USA-listed PureTech Health today announced the launch of a new founded entity to be called Celea Therapeutics.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

Eli Lilly has announced positive top-line results from the Phase III BRUIN CLL-314 trial of Jaypirca (pirtobrutinib), a ...

The US Food and Drug Administration (FDA) has announced the fiscal year 2024 Report on the State of Pharmaceutical Quality ...

Sweden’s Enzymatica has appointed Sana Alajmovic as its new chief executive (CEO), succeeding Claus Egstrand, who has ...

Castleman’s disease (CD) refers to a group of rare lymphoproliferative disorders characterized by abnormal lymph node ...

USA-based Bionova Scientific, a full-service contract development and manufacturing organization (CDMO) for biologics and a subsidiary of Japanese technology company Asahi Kasei, has announced the ...

French manufacturer Sartorius Stedim Biotech and Nanotein Technologies, a developer of next-generation immune cell activation ...

Denmark-based IO Biotech’s shares traded 51% higher ahead of the morning bell at $2.74 after the company said that Cylembio ...